Shares of Laser Photonics Corporation (LASE) dropped 7.3% to $1.53 after the company priced a $5 million public equity offering at just $0.70 per share — a staggering 54% discount to the prior close of $1.65. For a micro-cap already burning cash and fighting to stay listed on Nasdaq, the deal signals desperation more than strategy, and it extends a punishing slide that has erased roughly 79% of the stock's value over the past year.

  • The Offering Price Tells You What Buyers Really Think the Stock Is Worth. At $0.70 a share, the deal implies roughly 7.14 million new shares flooding an existing base of about 38.6 million. Laser Photonics has 38.57 million shares outstanding, and that count has already increased by 47.13% in one year. This latest round means existing holders face another ~18% dilution — the ownership pie keeps getting sliced thinner. More importantly, sophisticated institutional buyers would not accept a 54% haircut unless they saw severe risk in paying anything close to the market price.

  • The Balance Sheet Left No Room to Negotiate. At March 31, 2026, Laser Photonics had just $1.6 million in cash and a working capital deficit of about $4.0 million. Management and auditors concluded that recurring losses, negative cash flows, and the working capital deficit raise "substantial doubt about the company's ability to continue as a going concern."

Over the trailing twelve months, the company generated only $8.3 million in revenue against a net loss of $17.5 million — a -209% net profit margin. With that backdrop, $5 million buys perhaps six to nine months of runway, not a turnaround.

  • Defense Headlines Haven't Translated Into Dollars. Q1 2026 revenue came in at just $0.9 million, down sharply from $2.3 million a year earlier, even as the company touted anti-drone system contracts and a Johnson & Johnson order. The CEO also recently took a health leave, with an interim leader named, adding leadership uncertainty at a critical moment.

  • Nasdaq Compliance Is Still a Live Wire. LASE faces a deadline to regain full Nasdaq compliance by November 16, 2026, with potential delisting if it fails.

Stockholders just approved warrant inducement agreements on June 26, making new Series A-5 and A-6 warrants exercisable — meaning even more shares could enter the market. For a stock already trading near its 52-week low of $0.38, the floor may not hold.